Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
Health 11 July 2023, 5:39 pm 1 minute Reuters exclusively reported that Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s (NOVOb.CO) Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply. Market Impact Shares of the Danish drugmaker fell 2.3% on Tuesday. Article…
As much as we love a good splurge every now and then, there’s nothing like getting your hands on a quality item that didn’t cost a fortune. But we all know that sometimes, a suspiciously affordable price tag can be a deterrent. What if the item doesn’t work, is cheap and breaks after just one…
You’re likely familiar with foods that aren’t good for your heart. But when it comes to your bladder, it’s possible that you haven’t considered the correlation between diet and peeing. Unless you’ve had a urinary tract infection, suffered from a leaky bladder, or experienced the need to pee frequently, it may not have crossed your…
Looking to reduce your exposure to plasticizers in the new year? Contrary to what you might think, shopping organic and avoiding plastic food packaging isn’t a surefire way to avoid harmful chemicals such as BPA and phthalates. According to new research from Consumer Reports, phthalates and bisphenols — two chemicals linked to various health risks such as…
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. Le Creuset is probably the most iconic brand in the…
The latest variant of the COVID-19 virus, JN.1, is now responsible for an estimated 15% to 29% of cases in the U.S. as of Dec. 8, according to a posted update from the Centers for Disease Control and Prevention (CDC). JN.1, which is currently the country’s fastest growing variant, is expected to continue to increase…